CG Oncology (CGON) Other financing activities (2023 - 2026)
CG Oncology (CGON) reported Other financing activities of $47000.0 for Q1 2026, down 79.74% on a YoY basis from $232000.0 in Q1 2025, and down 92.07% quarter-over-quarter from $593000.0 in Q4 2025.
CG Oncology (CGON) Other financing activities (2023 - 2026) Analysis & Trends
CG Oncology has reported Other financing activities for 4 years, with the latest figure at $47000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 79.74% year-over-year to $47000.0; the trailing twelve-month figure through Mar 2026 stood at $131000.0 (down 98.14% YoY), and the FY2025 full-year result was $316000.0, down 90.77% from the prior year.
- Other financing activities for Q1 2026 stood at $47000.0, down from $593000.0 in the prior quarter.
- The five-year high for Other financing activities was $6.8 million in Q4 2024, with the low at -$3.4 million in Q1 2024.
- Historically, Other financing activities has averaged $830888.9 across 4 years, with a median of $232000.0 in 2025.
- The largest YoY upside for Other financing activities was 106.85% in 2025 against a maximum downside of 2005.41% in 2025.
- CG Oncology's Other financing activities stood at $3.7 million in 2023, then surged by 85.53% to $6.8 million in 2024, then sank by 91.34% to $593000.0 in 2025, then tumbled by 92.07% to $47000.0 in 2026.
- The last three Other financing activities figures came in at $47000.0 (Q1 2026), $593000.0 (Q4 2025), and $270000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | CG Oncology | 5.16 Bn | 5.16 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 593,000.00 |
| Dec 31, 2025 | 593,000.00 |
| Sep 30, 2025 | 270,000.00 |
| Sep 30, 2025 | 270,000.00 |
| Jun 30, 2025 | -779,000.00 |
| Jun 30, 2025 | -779,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | 6.85 Mn |
| Dec 31, 2024 | 6.85 Mn |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -3.39 Mn |
| Mar 31, 2024 | -3.39 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Dec 31, 2023 | 3.69 Mn |